This content is from: Innovation

Terumo Buys CaridianBCT For $2.63B

Terumo will acquire U.S. blood transfusion technology firm, CaridianBCT Holding.

Terumo will acquire U.S. blood transfusion technology firm, CaridianBCT Holding, The Wall Street Journal reports. The Japanese medical device maker will pay $2.63 billion for the acquisition to Sweden’s Gambro, adds Reuters.

The Tokyo-based company plans to fund the acquisition with cash and bank loans. Terumo will buy all of the shares in Colorado-based CaridianBCT and seeks to complete the deal in April or May.

Click here for the story from The Wall Street Journal.

Click here for additional coverage from Reuters.



Related Content